Journal of Infection and Public Health最新文献

{"title":"Antibiotic resistance pattern of waterborne causative agents of healthcare-associated infections: A call for biofilm control in hospital water systems","authors":"Sahar Gholipour ,&nbsp;Mahnaz Nikaeen ,&nbsp;Farzaneh Mohammadi ,&nbsp;Davarkhah Rabbani","doi":"10.1016/j.jiph.2024.102469","DOIUrl":"https://doi.org/10.1016/j.jiph.2024.102469","url":null,"abstract":"<div><h3>Background</h3><p>In recent years, the global spread of antimicrobial resistance has become a concerning issue, often referred to as a “silent pandemic”. Healthcare-associated infections (HAIs) caused by antibiotic-resistant bacteria (ARB) are a recurring problem, with some originating from waterborne route. The study aimed to investigate the presence of clinically relevant opportunistic bacteria and antibiotic resistance genes (ARGs) in hospital water distribution systems (WDSs).</p></div><div><h3>Methods</h3><p>Water and biofilm samples (n = 192) were collected from nine hospitals in Isfahan and Kashan, located in central Iran, between May 2022 and June 2023. The samples were analyzed to determine the presence and quantities of opportunistic bacteria and ARGs using cultural and molecular methods.</p></div><div><h3>Results</h3><p><em>Staphylococcus</em> spp. were highly detected in WDS samples (90 isolates), with 33 % of them harboring <em>mec</em>A gene. However, the occurrences of <em>E. coli</em> (1 isolate), <em>Acinetobacter baumannii</em> (3 isolates), and <em>Pseudomonas aeruginosa</em> (14 isolates) were low. Moreover, several Gram-negative bacteria containing ARGs were identified in the samples, mainly belonging to <em>Stenotrophomonas</em>, <em>Sphingomonas</em> and <em>Brevundimonas</em> genera. Various ARGs, as well as <em>intI</em>1, were found in hospital WDSs (ranging from 14 % to 60 %), with higher occurrences in the biofilm samples.</p></div><div><h3>Conclusion</h3><p>Our results underscore the importance of biofilms in water taps as hotspots for the dissemination of opportunistic bacteria and ARG within hospital environments. The identification of multiple opportunistic bacteria and ARGs raises concerns about the potential exposure and acquisition of HAIs, emphasizing the need for proactive measures, particularly in controlling biofilms, to mitigate infection risks in healthcare settings.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S187603412400203X/pdfft?md5=2ce01e0d054103560738237fa2cffd0b&pid=1-s2.0-S187603412400203X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141244987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer","authors":"Wan-Hsuan Hsu ,&nbsp;Bo-Wen Shiau ,&nbsp;Ya-Wen Tsai ,&nbsp;Jheng-Yan Wu ,&nbsp;Po-Yu Huang ,&nbsp;Min-Hsiang Chuang ,&nbsp;Ting-Hui Liu ,&nbsp;Chih-Cheng Lai ,&nbsp;Tzu-Chieh Weng","doi":"10.1016/j.jiph.2024.05.053","DOIUrl":"https://doi.org/10.1016/j.jiph.2024.05.053","url":null,"abstract":"<div><h3>Backgrounds</h3><p>The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer was unclear. Therefore, this study was conducted to evaluate the usefulness of antiviral agents in the management of COVID-19 among patients with lung cancer.</p></div><div><h3>Methods</h3><p>Utilizing data from the TriNetX – a global health research network, a retrospective cohort study was conducted involving 2484 patients diagnosed with both lung cancer and COVID-19. Propensity score matching (PSM) was employed to create well-balanced cohorts. The study assessed the primary outcome of all-cause hospitalization or mortality within a 30-day follow-up.</p></div><div><h3>Results</h3><p>After PSM, the oral antiviral group exhibited a significantly lower risk of the primary composite outcome compared to the control group (6.1 % vs. 9.9 %; HR: 0.60; 95 % CI: 0.45–0.80). This association was consistent across various subgroups according to age, sex, vaccine status, type of oral antiviral agent, and lung cancer characteristics. Additionally, the oral antiviral group showed a lower risk of all-cause hospitalization (HR: 0.73; 95 % CI: 0.54–0.99) and a significantly lower risk of mortality (HR: 0.16; 95 % CI: 0.06–0.41).</p></div><div><h3>Conclusion</h3><p>The study suggests a favorable impact of oral antiviral therapy on the outcomes of COVID-19 in individuals with lung cancer and support the potential utility of oral antiviral agents in improving outcomes in this vulnerable population.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124001989/pdfft?md5=1f594ba33955e8e50e639c64fed79612&pid=1-s2.0-S1876034124001989-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alzheimer's disease risk associated with changes in Epstein-Barr virus nuclear antigen 1-specific epitope targeting antibody levels","authors":"Kyu-Young Sim ,&nbsp;Jaekyeung An ,&nbsp;So-Eun Bae ,&nbsp;Taewoo Yang ,&nbsp;Gwang-Hoon Ko ,&nbsp;Jeong-Ryul Hwang ,&nbsp;Kyu Yeong Choi ,&nbsp;Jung Eun Park ,&nbsp;Jung Sup Lee ,&nbsp;Byeong C. Kim ,&nbsp;Kun Ho Lee ,&nbsp;Sung-Gyoo Park","doi":"10.1016/j.jiph.2024.05.050","DOIUrl":"10.1016/j.jiph.2024.05.050","url":null,"abstract":"<div><h3>Background</h3><p>Alzheimer's disease (AD) is a neurodegenerative disorder influenced by age, sex, genetic factors, immune alterations, and infections. Multiple lines of evidence suggest that changes in antibody response are linked to AD pathology.</p></div><div><h3>Methods</h3><p>To elucidate the mechanisms underlying AD development, we investigated antibodies that target autoimmune epitopes using high-resolution epitope microarrays. Our study compared two groups: individuals with AD (n = 19) and non-demented (ND) controls (n = 19). To validate the results, we measured antibody levels in plasma samples from AD patients (n = 96), mild cognitive impairment (MCI; n = 91), and ND controls (n = 97). To further explore the invlovement of EBV, we performed epitope masking immunofluorescence microscopy analysis and tests to induce lytic replication using the B95–8 cell line.</p></div><div><h3>Results</h3><p>In this study, we analyzed high-resolution epitope-specific serum antibody levels in AD, revealing significant disparities in antibodies targeting multiple epitopes between the AD and control groups. Particularly noteworthy was the significant down-regulation of antibody (anti-DG#29) targeting an epitope of Epstein-Barr virus nuclear antigen 1 (EBNA1). This down-regulation increased AD risk in female patients (odds ratio up to 6.6), but not in male patients. Our investigation further revealed that the down-regulation of the antibody (anti-DG#29) is associated with EBV reactivation in AD, as indicated by the analysis of EBV VCA IgG or IgM levels. Additionally, our data demonstrated that the epitope region on EBNA1 for the antibody is hidden during the EBV lytic reactivation of B95–8 cells.</p></div><div><h3>Conclusion</h3><p>Our findings suggest a potential relationship of EBV in the development of AD in female. Moreover, we propose that antibodies targeting the epitope (DG#29) of EBNA1 could serve as valuable indicators of AD risk in female.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124001953/pdfft?md5=8c6e6495bc835fba222707bfdc405a5a&pid=1-s2.0-S1876034124001953-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antimicrobial resistance among pregnant women with urinary tract infections is on rise: Findings from meta-analysis of observational studies","authors":"Hanan M. Al Kadri ,&nbsp;Ashraf A. El-Metwally ,&nbsp;Atika A. Al Sudairy ,&nbsp;Raed A. Al-Dahash ,&nbsp;Badr F. Al Khateeb ,&nbsp;Sameera M. Al Johani","doi":"10.1016/j.jiph.2024.05.055","DOIUrl":"https://doi.org/10.1016/j.jiph.2024.05.055","url":null,"abstract":"<div><p>Pregnant women have a higher risk of urinary tract infections (UTIs) compared to non-pregnant women, making antibiotics necessary for treatment. However, prescribing antibiotics without culture and sensitivity tests may contribute to antimicrobial resistance. A meta-analysis using R was conducted to determine the prevalence of antibiotic resistance patterns in UTIs among pregnant women. We identified observational studies published in the last 10 years and used a random effects model to calculate the pooled prevalence. The prevalence of Gram-negative organisms causing UTIs in pregnant women was 67 %, while Gram-positive organisms were 22 %. The burden of Gram-positive organisms exhibiting antimicrobial resistance was very high at 95 %, primarily to ampicillin. The most common Gram-negative organisms exhibiting antimicrobial resistance were E. coli, Klebsiella, and Pseudomonas aeruginosa, while the most common Gram-positive organisms resistant to antibiotics were Staphylococcus aureus and coagulase-negative Staphylococcus. Sensitivity and culture testing are recommended for effective treatment in pregnant women with UTIs.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002004/pdfft?md5=338b63de2483f5b1c87f4ed4618bbd7a&pid=1-s2.0-S1876034124002004-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141290330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Successful treatment of invasive mycobacterium infection with interferon beta in a patient with Interferon-Gamma Receptor 1 deficiency","authors":"Fayhan Alroqi ,&nbsp;Abduarahman Almutairi ,&nbsp;Moza Alhammadi ,&nbsp;Shatha Alhamdi","doi":"10.1016/j.jiph.2024.102468","DOIUrl":"https://doi.org/10.1016/j.jiph.2024.102468","url":null,"abstract":"<div><p>Mendelian susceptibility to mycobacterial disease (MSMD) is caused by approximately 21 genetic defects, including a mutation in Interferon-Gamma Receptor 1 (IFNGR1). IFNGR1 deficiency leads to a loss of cellular responsiveness to type II Interferon (IFN-γ), which plays a significant role in controlling intracellular bacteria. This study explored the response of IFN–β therapy in a patient with partial IFNGR1 deficiency to treat invasive mycobacterial infection. The biological therapy was used successfully as an adjuvant to anti-mycobacterial medications to treat a 17-year-old girl with partial IFNGR1 deficiency who presented with a recurrent mycobacterial infection that extended to her central nervous system, which resulted in clinical and radiological improvement. This report suggests that activation of type I IFN through Signal Transducers and Activators of Transcription1 (STAT1) could bypass the early IFN-γ signaling defects and activate IFN-γ production. For that reason, IFN–β might be used as a beneficial adjuvant therapy for managing extensive central nervous system mycobacterial infection, especially in patients with IFNGR1 deficiency.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002028/pdfft?md5=44010a7a998a778c7015314b49742bf4&pid=1-s2.0-S1876034124002028-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141582691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Phenomics and genomic features of Enterococcus avium IRMC1622a isolated from a clinical sample of hospitalized patient","authors":"Reem AlJindan ,&nbsp;Nehal Mahmoud ,&nbsp;Doaa M. AlEraky ,&nbsp;Noor B. Almandil ,&nbsp;Sayed AbdulAzeez ,&nbsp;J. Francis Borgio","doi":"10.1016/j.jiph.2024.05.051","DOIUrl":"https://doi.org/10.1016/j.jiph.2024.05.051","url":null,"abstract":"<div><h3>Background</h3><p><em>Enterococcus avium (E. avium)</em> is a Gram-positive nosocomial pathogen that is commonly isolated from the alimentary tract. The objective of this functional genomics study was to identify the resistant genes by analyzing the genome of <em>E. avium</em> IRMC1622a, a type of bacteria found in feces collected from a patient at a Saudi Arabian tertiary hospital.</p></div><div><h3>Methods</h3><p>The bacterial strain IRMC1622a was identified by <em>16 S rRNA</em> sequencing as <em>Enterococcus</em> sp. The resistance phenomics were performed using VITEK® 2, and morphological analysis was achieved using a scanning electron microscope (SEM). Finally, the whole bacterial genome of the bacterial strain IRMC1622a was subjected to sequencing during October 2023 using Oxford Nanopore long-read sequencing technology, and mining for resistant genes.</p></div><div><h3>Results</h3><p>The results of antimicrobial resistant phenomics indicated that the IRMC1622a strain was sensitive to all tested antimicrobial agents except for erythromycin, and the same result was confirmed by genomic analysis in addition to other classes of antibiotics. SEM showed <em>E. avium</em> IRMC1622a is ovoid shape, in single cells (L 1.2797 ± 0.1490 µm), in pairs (L 1.7333 ± 0.1054 µm), and in chains (L 2.44033 ± 0.1978 µm). The <em>E. avium</em> IRMC1622a genome has 14 (in CARD) antimicrobial resistance genes that were identified with several mechanisms of antimicrobial resistance, such as the efflux pump and conferring antibiotic resistance. The present study revealed that the <em>E. avium</em> IRMC1622a genome contains a high number of genes associated with virulence factors, and 14 matched pathogenic protein families and predicted as human pathogen (probability score 0.855). We report two (IS<em>Enfa4</em> and IS<em>Efa5</em>) mobile genetic elements for the first time in the <em>E. avium</em> genome.</p></div><div><h3>Conclusions</h3><p>The study concludes that <em>E. avium</em> IRMC1622a is susceptible to all tested antibacterials except erythromycin. The IRMC1622a has 14 genes encoding antimicrobial resistance mechanisms, including the efflux pump and conferring antibiotic resistance. This could indicate a potential rise in <em>E. avium</em> resistance in healthcare facilities. These observations may raise concerns regarding <em>E. avium</em> resistance in healthcare. We need more research to understand the pathophysiology of <em>E. avium</em>, which leads to hospital-acquired infections.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124001977/pdfft?md5=ed21f311dee5042edddc8c9ad94b2fab&pid=1-s2.0-S1876034124001977-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141240427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endogenous bacterial endophthalmitis in an HIV patient with uncontrolled diabetes: A case of rare ocular complication","authors":"Yahya Ali Mohzari ,&nbsp;Oweida Fahad AlDosary ,&nbsp;Reem F. Bamogaddam ,&nbsp;Munira AlHussaini ,&nbsp;Hamad Al Alyami ,&nbsp;Ahmad Alrashed ,&nbsp;Ahmad Alamer","doi":"10.1016/j.jiph.2024.05.049","DOIUrl":"https://doi.org/10.1016/j.jiph.2024.05.049","url":null,"abstract":"<div><p>Endogenous bacterial endophthalmitis (EE) is an intraocular infection with a poor prognosis. Timely diagnosis and prompt treatment are crucial to prevent vision loss. In this communication, we describe a case of EE caused by <em>Streptococcus pyogenes</em> (Group A Streptococcus [GAS]) in an HIV-positive patient with poorly controlled type 2 diabetes mellitus (DM). A 60-year-old man with a history of HIV and poorly controlled type 2 diabetes, presented with progressive blurry vision, left eye pain, redness, and headache. EE was diagnosed based on the clinical presentation and gram stain analysis of blood culture. Treatment with vitreous tap, intravitreal, topical antibiotics, and systemic antibiotics significantly improved the patient's symptoms. The case highlights the rarity of GAS as a causative agent of EE, particularly in patients with risk factors such as HIV infection and DM.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124001965/pdfft?md5=0c2cf1b73ea0f88ae6a459557aa20954&pid=1-s2.0-S1876034124001965-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141292301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Potential association between COVID-19 infections and the declining incidence of lung cancers","authors":"Josef Yayan,&nbsp;Diana Saleh,&nbsp;Karl-Josef Franke","doi":"10.1016/j.jiph.2024.05.046","DOIUrl":"10.1016/j.jiph.2024.05.046","url":null,"abstract":"<div><h3>Background</h3><p>The COVID-19 pandemic has significantly impacted global health and prompted studies on its effects across various diseases. Recent data suggest a potential correlation between COVID-19 and a decrease in lung cancer incidence. This study examines the association between COVID-19 infection and changes in lung cancer cases.</p></div><div><h3>Material and methods</h3><p>We conducted a retrospective analysis of medical records from Clinic Lüdenscheid, Germany, from January 1, 2018, to December 31, 2021, comparing lung cancer cases before and during the pandemic. Demographic characteristics and cancer stages were also assessed.</p></div><div><h3>Results</h3><p>We evaluated 523 patients; 269 pre-COVID and 254 during COVID. While the overall number of cases declined, a significant increase in advanced stage cancers was noted during COVID (<em>P</em> = 0.04). The adjusted incidence rates showed a nuanced decrease from approximately 33 cases per 100,000 pre-COVID to 31 during COVID.</p></div><div><h3>Conclusion</h3><p>This retrospective study suggests a modest decline in lung cancer incidence and an increase in advanced stages during COVID. Further comparisons with national data indicate a similar trend across Germany, with a decrease of about 3 % in lung cancer diagnoses post-2020, highlighting potential pandemic impacts on cancer detection.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124001862/pdfft?md5=70c20a611ef3df8f4fc6e4133e20f4bd&pid=1-s2.0-S1876034124001862-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141186084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment","authors":"Min-Chi Chang ,&nbsp;Ping-Feng Wu ,&nbsp;Yu-Chien Ho ,&nbsp;Wen-Ying Lin ,&nbsp;Chia-Ying Wu ,&nbsp;Szu-Yu Liu ,&nbsp;Chia-Jen Liu ,&nbsp;Yi-Tsung Lin","doi":"10.1016/j.jiph.2024.05.048","DOIUrl":"10.1016/j.jiph.2024.05.048","url":null,"abstract":"<div><h3>Background</h3><p>The use of remdesivir in patients with coronavirus disease 2019 (COVID-19) and severe renal impairment has been approved; however, limited clinical data exist. Accordingly, we aimed to compare outcomes and adverse events associated with remdesivir in hospitalized patients with COVID-19, with and without severe renal impairment.</p></div><div><h3>Methods</h3><p>Hospitalized patients with COVID-19 undergoing a 5-day remdesivir course at Taipei Veterans General Hospital from April 1 to July 31, 2022, were enrolled. Comparative analysis of outcomes and safety between patients with or without severe renal impairment (estimated glomerular filtration rate of &lt; 30 mL/min per 1.73 m²) were conducted. Prognostic factors associated with 28-day mortality in patients with severe renal impairment were investigated using logistic regression analysis.</p></div><div><h3>Results</h3><p>A total of 671 hospitalized patients, including 132 patients with severe renal impairment, who received a 5-day course of remdesivir were analyzed. The 28-day mortality was higher in patients with severe renal impairment than in patients without severe renal impairment (15.2% vs. 7.8%). The proportion of patients with acute kidney injury (AKI) and deteriorated liver function after completing remdesivir therapy was similar between the patients with and without severe renal impairment, and the recovery rate of AKI was similar in both groups. The sequential organ failure assessment score was an independent factor associated with 28-day mortality in patients with severe renal impairment.</p></div><div><h3>Conclusions</h3><p>Remdesivir was well-tolerated in hospitalized patients with COVID-19, regardless of renal function. Our findings support the recent recommendation to administer remdesivir in patients with severe renal impairment.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124001874/pdfft?md5=945fcfc427f727e9ce721140f0adae67&pid=1-s2.0-S1876034124001874-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141130692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antimicrobial stewardship programs in acute-care hospitals: A multicenter assessment of structure, process, and outcome indicators in Italy and Spain","authors":"Giuseppina Lo Moro ,&nbsp;Noemi Marengo ,&nbsp;Alessandro Mara ,&nbsp;José Ramón Paño Pardo ,&nbsp;Sergi Hernandez ,&nbsp;Ester Fusté ,&nbsp;Miquel Pujol ,&nbsp;Carla Maria Zotti ,&nbsp;Enric Limón ,&nbsp;Costanza Vicentini","doi":"10.1016/j.jiph.2024.05.045","DOIUrl":"10.1016/j.jiph.2024.05.045","url":null,"abstract":"<div><h3>Background</h3><p>Antimicrobial stewardship (AMS) programs have been differently implemented across Europe. This study primarily aimed to compare AMS in two European regions. Secondarily, the study explored the COVID-19 pandemic impact on surrogate outcome indicators of AMS.</p></div><div><h3>Methods</h3><p>A retrospective observational study was conducted in Piedmont (Italy) and Catalonia (Spain). AMS programs were compared through structure and process indicators in 2021. Changes in surrogate outcome indicators (antimicrobial usage; alcohol-based sanitizer consumption; antimicrobial resistance, AMR) from 2017 to 2021 described the pandemic impact.</p></div><div><h3>Results</h3><p>Seventy-eight facilities provided structure and process indicators. Catalonia showed better structure scores (p &lt; 0.001) and less dispersion in both indicators. The greatest areas to improve were accountability (Piedmont) and diversification of strategies (Catalonia). Overall, the regions reported consistent changes in outcome indicators. Antimicrobial usage decreased in 2020, returning to near-pre-pandemic levels in 2021. Alcohol-based sanitizer consumption surged in 2020, then dipped remaining above pre-pandemic levels. AMR trends were minimally affected.</p></div><div><h3>Conclusions</h3><p>The centralized approach of Catalonia ensured consistent attainment of quality objectives across all facilities, but it may limit facility-specific strategies. In Piedmont, accountability remain one of the most critical factors as in previous years. The pandemic did not substantially disrupt surrogate outcome measures of AMS. However, the data on AMR suggest that maintaining vigilance against this issue remains paramount.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":null,"pages":null},"PeriodicalIF":6.7,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124001850/pdfft?md5=e05dfd88d6cf8fb049e5572aaecad642&pid=1-s2.0-S1876034124001850-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141138585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}